Clinical Trial Update: Nexalin Therapy for the Treatment of Depressive Symptoms [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Nexalin Therapy for depressive symptoms has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Nexalin Therapy

Snippet

Sponsor: Kalaco Scientific, Inc. | Conditions: Depression | Phase 2 | Status: COMPLETED